close

Blogs > Health Care and Life Sciences Law Blog

False Claims Act

Jan 16, 2019

DOJ Recovers $2.8 Billion in 2018 False Claims Act Cases

The Department of Justice (DOJ) obtained $2.8 billion in settlements and judgements from False Claims Act civil cases in fiscal year 2018.  Of this amount, $2.5 billion, (89%), involved recoveries from the health care industry, including drug and medical device manufacturers, managed care providers, hospitals, pharmacies, hospice organizations, laboratories, and physicians. » Read More

Oct 17, 2018

Exclusion Implications of Entering into False Claims Act Settlements

According to the Office of Inspector General (OIG), the government’s primary civil tool for addressing health care fraud is the False Claims Act (FCA).  Most FCA cases are resolved through settlement agreements in which the government alleges fraudulent conduct and the settling parties do not admit liability. » Read More

May 25, 2018

Administering of Non FDA-Approved, Foreign Drugs Results in Criminal Conviction and Payment for False Claims Act Violation

In a recent press release, the United States Attorney’s Office for the Northern District of New York announced that a Poughkeepsie physician and his wife were sentenced for a misdemeanor for ordering and administering to patients, drugs that were not approved by the FDA and were obtained from foreign sources. » Read More

Want to receive these blogs in an email? Subscribe here:

Categories